PTC Inc. has recently released its 10-K report, detailing its financial performance for the fiscal year ending September 30, ...
Seaport-based PTC Inc. (Nasdaq: PTC), one of the state's largest public companies by revenue, added 270 workers in the 12 ...
Utley has another chance to get into Cooperstown after a solid debut on the ballot last year. Here’s his case and nine other ...
Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...
Kebilidi is the first gene therapy approved by the FDA for administration directly into the brain, given via a cannula during ...
A tropical disturbance building in the Caribbean Sea has been designated as Potential Tropical Cyclone 19 by the National ...
These live maps from the FOX Forecast Center show the latest information and models on Potential Tropical Cyclone Nineteen, ...
The monkeys made a break for it Wednesday after an employee at the Alpha Genesis facility in Yemassee didn't fully lock a ...
William Blair analyst Sami Corwin maintained a Buy rating on PTC Therapeutics (PTCT – Research Report) today. The company’s shares closed yesterday at $42.96. Corwin covers the Healthcare sector, ...
Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth-quarter conference call. (Operator Instructions) I would now like to turn the call over to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback